Klalit Health Services
The largest of Israel's four statutory health funds, covering roughly half the population through an integrated network of community clinics and owned hospitals.
Klalit Health Services (Hebrew: Sherutei Bri'ut Klalit) is the largest of Israel's four statutory health funds — covering approximately 4.7 million members, roughly half of all Israeli residents. Klalit operates the only vertically integrated payer-provider system in Israel, running community clinics, specialist centers, and eight owned general hospitals plus one children's hospital. It is licensed under the 1995 National Health Insurance Law alongside Maccabi Healthcare Services, Meuhedet, and Leumit. Founded in 1911, it predates the State of Israel by 37 years and is the single largest civilian employer in the country.
Founding and historical structure
Klalit was established in 1911 as Kupat Holim Klalit — a mutual-aid health insurance cooperative founded by agricultural workers in Ottoman Palestine. It formally became the health arm of the Histadrut (General Federation of Labor in the Land of Israel) in 1920, and for the following seven decades operated as an integral part of the Histadrut labor apparatus, funded by labor-federation dues alongside member premiums. The Histadrut connection made Klalit the largest and most politically embedded institution in the pre-state Yishuv economy and, for decades after independence, the dominant provider of Israeli medical care.
The 1995 National Health Insurance Law separated Klalit from the Histadrut. The law universalized health coverage, established Bituach Leumi (National Insurance Institute) as the sole collector of health-tax revenue, and created a capitation-based redistribution formula that transfers funds from the Ministry of Finance to the four Kupot Holim in proportion to their membership. Klalit today operates as a non-profit public-benefit corporation supervised by the Ministry of Health.
Operating model
Klalit is the only Israeli health fund that owns and operates a major hospital network alongside its community-clinic system. The hospital arm includes Beilinson Hospital (Petah Tikva), Schneider Children's Medical Center (Petah Tikva), Soroka University Medical Center (Beer Sheva), Carmel Medical Center (Haifa), Kaplan Medical Center (Rehovot), HaEmek Medical Center (Afula), Meir Medical Center (Kfar Saba), Yoseftal Medical Center (Eilat), and Lin Medical Center (Haifa). This vertical integration distinguishes Klalit from peer funds, which operate as payers contracting with independent hospital systems.
On the community side, Klalit operates more than 1,400 clinics across Israel, including neighborhood family-medicine clinics, specialist clinics, women's health centers, mother-and-child clinics (Tipat Halav for infants and expectant mothers), and dedicated pharmacies. The community network reaches every geographic area of Israel, including the periphery — the Negev, the Galilee, and the Arab-Israeli localities — where Klalit is often the sole full-service Kupah.
Service entitlements are defined annually by the Sal HaTziyud (Health Services Basket) and accessed through clinic referrals and the Tofes 17 commitment document — the referral form that authorizes specialist care and hospital treatment at Kupah expense.
Scale and workforce
Klalit employs approximately 45,000 people across its clinics, hospitals, and administrative arms — making it the largest single civilian employer in Israel. Its physician cohort includes several thousand family physicians, specialists, and hospital-based clinicians. The organization is the largest single purchaser of pharmaceuticals and medical devices in the Israeli market, which gives it significant procurement leverage in drug and device pricing negotiations mediated through the Ministry of Health.
Position in the Israeli payer system
Klalit's scale, hospital ownership, and geographic footprint make it the de facto baseline against which the other three Kupot Holim are benchmarked on cost, access, and clinical performance. Its dominance in the periphery — where it captures 70 percent or more of local membership in many Negev and Galilee towns — creates a structural coverage obligation that the smaller funds cannot replicate. Klalit accepts every eligible member without preference. That universal-access obligation, combined with hospital ownership, means Klalit carries a costlier average risk pool than Maccabi or Meuhedet.
Klalit's clinical-research infrastructure is one of the deepest in the world. The organization operates the Klalit Research Institute, which has published extensively on population health, chronic-disease management, vaccine efficacy (including the peer-reviewed early real-world studies of COVID-19 vaccination effectiveness), and outcomes research using anonymized data from tens of millions of member-years of electronic medical records. Sheba ARC and Klalit Innovation are the two most active clinical-trial and real-world-evidence partners for Israeli and multinational pharmaceutical companies operating in the country.
Governance and funding
Klalit is governed by a member-elected assembly and a board that appoints the CEO. The elected structure reflects Klalit's mutual-aid origins and gives the organization a formal member-representation channel that the other three Kupot Holim do not run at the same scale. Operating revenue comes from three sources: statutory capitation transfers from Bituach Leumi (the largest share), member co-payments and supplemental insurance premiums, and independent revenue from hospital services provided to non-Klalit patients on a contracted basis.
Supplemental insurance — Klalit Mushlam and Klalit Platinum — is optional coverage that Klalit members can purchase to expand entitlements beyond the statutory Sal HaTziyud basket. Roughly 85 percent of Klalit members carry supplemental coverage, which funds elective procedures, dental care, expanded pharmacy formularies, and access to private-market specialists.
Why it matters
Klalit is the anchor institution of the Israeli healthcare system. Its combined payer-provider structure, its geographic universality, its research infrastructure, and its scale as the country's largest civilian employer make it functionally impossible to reform the Israeli healthcare system without Klalit's participation. Every major Israeli health-policy debate — pharmaceutical pricing, hospital capacity, primary-care physician training, digital-health rollout, periphery access — runs through Klalit as either the largest counterparty or the largest single implementation partner.
One in two Israelis is a Klalit member. That number has been roughly stable for a decade. It is the number that defines the Israeli payer market.
Primary Sources
- Klalit Health Services — annual reports and clinical-outcomes data
- Ministry of Health — Kupot Holim regulation and Sal HaTziyud basket
- Bituach Leumi — capitation transfer formula and health-tax collection
- Klalit Research Institute — published research and real-world-evidence studies
- 1995 National Health Insurance Law — foundational statute
